Clin Osteol 2008; 13(3): 102-105

Osteoporosis and systemic sclerosisReview articles

P, Masaryk, J. Lukáč, A. Letkovská, J. Rovenský

Authors review actual knowledge about problem of relation of systemic sclerosis and osteoporosis. On the basis of published data sys­ temic sclerosis can not be confirmed as an independent risk factor of osteoporosis. Many other factors coincide here: preliminary me­ nopause, low muscle mass, low fat mass, low BMI, extension of cutaneous defects, presence of calcinosis, other organs damage and drugs. Seriousness of bone injury is comparable with that seen in rheumatoid arthritis.

Keywords: systemic sclerosis, osteoporosis

Published: December 11, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
P, Masaryk, Lukáč J, Letkovská A, Rovenský J. Osteoporosis and systemic sclerosis. Osteologický bulletin. 2008;13(3):102-105.
Download citation

References

  1. Lukáč J: Systémová skleróza - sklerodermia, Šeba, Puchov,1998, 368s.
  2. Louks J, Pope 2004;34:678-682.
  3. Yuen SY, Rochwerg B, Ouimet J, Pope JE: Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis an flammatory musculoskeletal conditions, J Rheumatol, 2008 Apr 15 (Epub).
  4. Blocka KLN, Basset LW, Furst DE: The artropathy of advanced progressi temic sclerosis: a radiographic survey. Arthritis Rheum 1981;24:874-884. Go to original source...
  5. La Montagna G, Vatti M, Valentini G, Tirri G: Osteopenia in systemic sclero Evidence of a participating role of earlier menopause. Clin Rheumatol 1991;10: 18-22. Go to original source...
  6. Serup J, Hagdrup HK, Tvedegaard E: Bone mineral content in systemi measured by photon absorptiometry, Acta Dermatovener 1983;63:235-237. Go to original source...
  7. Di Munno O, Mazzantini M, Massei P, Ferdeghini M, Pitaro O, Latorraca A, ri C: Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis, Clin Rheumatol 1995;14(4):407-412. Go to original source...
  8. Carbone L, Tylavsky F, Wan J, McKown K, Cheng S: Bone mineral density in scleroderma, Rheumatology 1999;38:371-372. Go to original source...
  9. Da Silva HC, Szejnfeld VL, Assis LS, Sato EI: Study of bone density in syste scleroderma, Rev Assoc Med Bras 1997;43[1]:40-46. Go to original source...
  10. Neumann K, Wallace DJ, Metzger AL: Osteoporosis - less than expected in pa­ tients with scleroderma? J Rhematol 2000;27:1822-23.
  11. Frediani B, Baldi F, Falsetti P, Acciai C, Filippou G, Spreafico A, Chelli pperucci C, Filipponi P, Galeazzi M, Marcolongo R: Bone mineral density in pa­ tients with systemic sclerosis, Ann Rheum Dis 2004;63:326-327. Go to original source...
  12. Frediani B, Baldi F, Falsetti P, Acciai C, Filippou G, Spreafico A, Chellini F, pperucci C, Filipponi P, Galeazzi M, Marcolongo R: Bone mineral density in pa­ tients with systemic sclerosis, Ann Rheum Dis 2004;63:326-327. Go to original source...
  13. Sampaio-Barros PD, Costa-J^iva L, Filardi S, Sachetto Z, Samara AM, MarquesNeto JF: Prognostic factors of low bone mineral density in systemic sclerosis, Clin Exp Rheumatol 2005;23:180-184.
  14. Souza RB, Borges CT, Takayama L, Aldrighi JM, Pereira RM: Systemic sclerosis and bone loss: the role of the disease and body composition, Scand J Rheumatol 2006;35[5]:384-387. Go to original source...
  15. La Montagna G, Baruffo A, Abbadesa S, Maja L, Tirri R: Evidence for bone re­ sorption in systemic sclerosis, J Rheumatol 1995;22:797-799.
  16. Stone PJ, Korn JH, North H: Cross-linked elastin and collagen degradation pro­ ducts in the urine of patients with scleroderma, Arthritis Rheum 1995;38:517-524. Go to original source...
  17. Ištók R, Czirjak I, Lukáč J, Stančíková M, Rovenský J: Increased urinary pyridinoline cross-link compounds of collagen in patients with systemic sclerosis and Raynaud's phenomenon, Rheumatology (Oxford) 2001;40:140-146. Go to original source...
  18. Ištók R, Czirjak I, Lukáč J, Stančíková M, Rovenský J: Increased urinary pyridinoline cross-link compounds of collagen in patients with systemic sclerosis and Raynaud's phenomenon, Rheumatology (Oxford) 2001;40:140-146. Go to original source...
  19. Alexandersson BT, Geirsson AJ, Olafsson I, Franzson L, Sigurdsson G, Gudbjornsson B: Bone mineral density and bone turnover in systemic sclerosis, Laeknabladid 2007;93[7-8]:535-541.
  20. Masaryk P, Letkovská A, Lukáč J, Žlnay D, Raffayová H, Rovenský J: Kostná denzita u vybraných zápalovýách reumatických chorôb, Osteol Bull 2007;12[3]: 132-132.




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.